HomeSYRS • NASDAQ
add
Syros Pharmaceuticals Inc
Previous close
$6.22
Day range
$6.22 - $6.64
Year range
$2.09 - $8.17
Market cap
174.14M USD
Avg Volume
86.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.27M | -15.38% |
Net income | -3.71M | 84.41% |
Net profit margin | — | — |
Earnings per share | -0.10 | 88.24% |
EBITDA | -30.59M | 6.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 108.30M | -34.68% |
Total assets | 134.73M | -34.38% |
Total liabilities | 119.67M | 21.41% |
Total equity | 15.06M | — |
Shares outstanding | 26.73M | — |
Price to book | 11.11 | — |
Return on assets | -51.04% | — |
Return on capital | -99.45% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.71M | 84.41% |
Cash from operations | -31.10M | 15.73% |
Cash from investing | -24.64M | 4.30% |
Cash from financing | -265.00K | -400.00% |
Net change in cash | -56.00M | 10.68% |
Free cash flow | -20.46M | 21.32% |
About
Founded
2011
Website
Employees
68